Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Investec Cuts Barclays To Sell From Hold

Fri, 17th Jul 2015 08:32

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
Investec Cuts Barclays To Sell From Hold, Price Target Lowered To 265p From 270p
----------
HSBC RAISES CENTRICA TO 'BUY' ('HOLD')
----------
DEUTSCHE BANK TRIMS ST JAMES'S PLACE PRICE TARGET BY 2% TO 1030 PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS BAE SYSTEMS PRICE TARGET TO 485 (495) PENCE - 'HOLD'
----------
EXANE BNP CUTS ASTRAZENECA PRICE TARGET TO 5500 (5800) PENCE - 'OUTPERFORM'
----------
TRADERS: BARCLAYS CUTS ROLLS-ROYCE PRICE TARGET TO 680 (830) PENCE
----------
TRADERS: BARCLAYS CUTS AVIVA PRICE TARGET TO 636 (637) PENCE
----------
UBS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1400 (1500) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS ANGLO AMERICAN PRICE TARGET TO 950 (1090) PENCE - 'HOLD'
----------
TRADERS: HSBC CUTS INMARSAT PRICE TARGET TO 920 (980) PENCE - 'HOLD'
----------
S&P CAPITAL IQ CUTS RIO TINTO PRICE TARGET TO 2750 (2900) PENCE - 'HOLD'
----------
SOCGEN CUTS SHELL B PRICE TARGET TO 2370 (2500) PENCE - 'BUY'
----------
FTSE 250
----------
JPMORGAN CUTS ESSENTRA PRICE TARGET TO 1014 (1026) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES JLT GROUP PRICE TARGET TO 1260 (1250) PENCE - 'OVERWEIGHT'
----------
NOMURA CUTS MITCHELLS & BUTLERS PRICE TARGET TO 504 (540) PENCE - 'BUY'
----------
NOMURA RAISES MARSTONS PRICE TARGET TO 152 (143) PENCE - 'NEUTRAL'
----------
NOMURA CUTS WETHERSPOON TO 'REDUCE' ('NEUTRAL') - TARGET 796 PENCE
----------
NOMURA CUTS RESTAURANT GROUP TO 'NEUTRAL' ('BUY') - TARGET 810 PENCE
----------
BERENBERG CUTS BODYCOTE PRICE TARGET TO 650 (684) PENCE - 'HOLD'
----------
TRADERS: CANACCORD RAISES TULLOW OIL PRICE TARGET TO 380 (320) PENCE
----------
TRADERS: CANACCORD CUTS PREMIER OIL PRICE TARGET TO 90 (100) PENCE
----------
TRADERS: CANACCORD CUTS OPHIR ENERGY PRICE TARGET TO 160 (200) PENCE
----------
TRADERS: CANACCORD CUTS CAIRN ENERGY PRICE TARGET TO 200 (205) PENCE
----------
SOCGEN RAISES ICAP PRICE TARGET TO 505 (370) PENCE - 'HOLD'
----------
UBS CUTS OCADO TO 'NEUTRAL' ('BUY') - TARGET 480 (435) PENCE
----------
TRADERS: JEFFERIES RAISES HENDERSON GROUP PLC TO 'HOLD' ('UNDERPERFORM')
----------
MAIN MARKET AND AIM
----------
TRADERS: CANACCORD CUTS FALKLAND OIL & GAS PRICE TARGET TO 26 (30) PENCE
----------
PANMURE RAISES HUTCHISON CHINA MEDITECH PRICE TARGET TO 1750 (1650) P - 'BUY'
----------
PANMURE RAISES 888 HOLDINGS TO 'HOLD' ('SELL') - TARGET 150 (96) PENCE
----------
LIBERUM INITIATES FASTJET WITH 'BUY' - TARGET 275 PENCE
----------
TRADERS: CANACCORD CUTS ROCKHOPPER EXPLORATION PRICE TARGET TO 170 (175) PENCE
----------
TRADERS: CANACCORD CUTS LEKOIL PRICE TARGET TO 35 (40) PENCE
----------
TRADERS: CANACCORD CUTS IGAS ENERGY PRICE TARGET TO 60 (75) PENCE
----------
TRADERS: CANACCORD CUTS GULF KEYSTONE PRICE TARGET TO 30 (35) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.